Clinical features, etiology and survival in patients with restrictive cardiomyopathy: A single center experience.

Justyna A Szczygieł,Piotr Michałek,Grażyna Truszkowska,Joann Drozd-Sokołowska,Aleksandra Wróbel,Maria Franaszczyk,Monika Gawor-Prokopczyk,Łukasz Mazurkiewicz,Mateusz Ziarkiewicz,Anna Waszczuk-Gajda,Marta Legatowicz-Koprowska,Ewa Walczak,Piotr Stawiński,Anna Lutyńska,Rafał Płoski,Wiesław W Jędrzejczak,Zofia T Bilińska,Jacek Grzybowski

Kardiologia polska（2023）

引用 0|浏览12

暂无评分

摘要

Genetic testing should be considered in every patient with RCM where light-chain amyloidosis has been excluded. Survival remains poor regardless of etiology. Increased concentrations of GDF15, hs-TNT, NT-proBNP and pericardial effusion are associated with worse prognosis. Further studies are warranted.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要